加强新冠肺炎对心血管系统损害的研究

肖颖彬

doi:10.16016/j.1000-5404.202101049

您当前的位置：

首页 >

文章列表页 >

加强新冠肺炎对心血管系统损害的研究

专家述评 | 更新时间：2026-01-09

- 加强新冠肺炎对心血管系统损害的研究
- Intensifying the research on detrimental effects of COVID-19 on cardiovascular system
- 第三军医大学学报 2021年43卷第3期页码：183-187
- 作者机构：
  
  400037 重庆，陆军军医大学(第三军医大学)第二附属医院全军心血管外科研究所
- 作者简介：
  
  [ 肖颖彬，博士，教授，主任医师，博士研究生导师。担任中华医学会胸心血管外科分会常务委员，中国医师协会心血管外科医师分会常务委员，全军胸心血管外科专业委员会主任委员。获国家科技进步二等奖1项，重庆市科技进步一等奖等省部级奖励10余项。主要从事婴幼儿和复杂先心病、危重瓣膜病、大动脉疾病和冠心病外科治疗、心肌细胞慢性缺氧损害分子机制和保护机制等研究。E-mail：xiaoyb@vip.sina.com XIAO Yingbin, E-mail: xiaoyb@vip.sina.com
- 基金信息：
- DOI：10.16016/j.1000-5404.202101049
  中图分类号： R54;R563.1
- 收稿：2021-01-06，
  
  修回：2021-01-28，
  
  纸质出版：2021-02-15
- 稿件说明：
移动端阅览
肖颖彬. 加强新冠肺炎对心血管系统损害的研究[J]. 第三军医大学学报, 2021,43(3):183-187.

Yingbin XIAO. Intensifying the research on detrimental effects of COVID-19 on cardiovascular system[J]. Journal of Third Military Medical University, 2021, 43(3): 183-187.
肖颖彬. 加强新冠肺炎对心血管系统损害的研究[J]. 第三军医大学学报, 2021,43(3):183-187. DOI： 10.16016/j.1000-5404.202101049.

Yingbin XIAO. Intensifying the research on detrimental effects of COVID-19 on cardiovascular system[J]. Journal of Third Military Medical University, 2021, 43(3): 183-187. DOI： 10.16016/j.1000-5404.202101049.

摘要

新型冠状病毒肺炎(新冠肺炎，coronavirus disease 2019，COVID-19)大流行在全球范围内持续施虐。多数轻症患者无明显症状，重症患者的临床表现主要以肺炎和顽固性低氧血症为主。部分重症患者甚至出现全身多器官损伤。既往存在慢性心血管病史的患者，或感染期间新发的心血管系统损害是导致新冠肺炎患者死亡的危险因素。新型冠状病毒(新冠病毒，SARS-CoV2)感染导致心血管系统损伤的机制尚不清楚，可能与病毒直接侵犯心肌细胞、严重的低氧血症和全身炎症因子的释放有关。因此，要加强新冠肺炎导致心血管系统损害治疗策略的相关研究，重视疫情下心血管病危重症患者的救治工作。

Abstract

The pandemic of the Coronavirus Disease 2019 (COVID-19) is ongoing exacerbated worldwide. The clinical consequence of this disease was characterized with pneumonia and hypoxemia

even systemic injuries

especially in severe cases. Patients with underlying chronic cardiovascular diseases

or complicated with new onsetting cardiovascular problems

were correlated with a high mortality. However

the mechanisms of myocardial and vascular damage complicated with SARS-CoV-2 viral infection have not been clarified yet. They might be correlated with direct viral invasion

severe hypoxemia

and systemic cytokine storm. Hence

the therapeutic strategy for SARS-CoV2 viral infections related to myocardial and vascular damage

and the protocol for critical ill patients with emergent cardiovascular problems need comprehensive research urgently.

关键词

Keywords

references

[World Health Organization. WHO coronavirus disease (COVID-19) dashboard[EB/OL ] . [2021-01-27 ] . https://covid19.who.int/ https://covid19.who.int/ .

ZHAO Y, ZHAO Z X, WANG Y J, et al . Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2[J ] . Am J Respir Crit Care Med, 2020, 202(5):756-759.DOI:10.1101/2020.01.26.919985.

HOFFMANN M, KLEINE-WEBER H, SCHROEDER S, et al . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor[J ] . Cell. 2020, 181(2):271-280.e8. DOI: 10.1016/j.cell.2020.02.052.

肖颖彬.重视新型冠状病毒肺炎对心脏的损害[J].西部医学, 2020(3):313-315.DOI:10.3969/j.issn.1672-3511.2020.03.001.

XIAO Y B.Pay attention to the heart damage of corona virus disease 2019[J]. Med J West China, 2020(3):313-315.DOI:10.3969/j.issn.1672-3511.2020.03.001.

BLANCO-MELO D, NILSSON-PAYANT B E, LIU W C, et al . Imbalanced host response to SARS-CoV-2 drives development of COVID-19[J ] . Cell, 2020, 181(5): 1036-1045.e9. DOI:10.1016/j.cell.2020.04.026.

[CHEN L, LIU Y, WU J, et al . Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection[J ] . Aging (Albany NY), 2021.[Online ahead of print ] . DOI: 10.18632/aging.202375 http://dx.doi.org/10.18632/aging.202375 ..

SOUTH A M, DIZ D I, CHAPPELL M C.COVID-19, ACE2, and the cardiovascular consequences[J]. Am J Physiol Heart Circ Physiol, 2020, 318(5):H1084-H1090. DOI: 10.1152/ajpheart.00217.2020.

LIU P P, BLET A, SMYTH D, et al . The science underlying COVID-19: implications for the cardiovascular system[J ] . Circulation, 2020, 142(1): 68-78. DOI:10.1161/CIRCULATIONAHA.120.047549.

HUANG C L, WANG Y M, LI X W, et al . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J ] . Lancet, 2020, 395(10223): 497-506. DOI:10.1016/s0140-6736(20)30183-5.

ZHOU F, YU T, DU R H, et al . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J ] . Lancet, 2020, 395(10229): 1054-1062. DOI:10.1016/S0140-6736(20)30566-3.

CHEN N S, ZHOU M, DONG X, et al .Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J ] . Lancet, 2020, 395(10223):507-513. DOI: 10.1016/S0140-6736(20)30211-7.

GUAN W J, NI Z Y, HU Y, et al .Clinical characteristics of coronavirus disease 2019 in China[J ] . N Engl J Med, 2020, 382(18):1708-1720.DOI: 10.1056/NEJMoa2002032.

TAVAZZI G, PELLEGRINI C, MAURELLI M, et al . Myocardial localization of coronavirus in COVID-19 cardiogenic shock[J ] . Eur J Heart Fail, 2020, 22(5): 911-915. DOI:10.1002/ejhf.1828.

YU C M, WONG R S M, WU E B, et al . Cardiovascular complications of severe acute respiratory syndrome[J ] . Postgrad Med J, 2006, 82(964): 140-144. DOI:10.1136/pgmj.2005.037515.

WANG D, HU B, HU C, et al .Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J ] . JAMA, 2020, 323(11):1061-1069. DOI: 10.1001/jama.2020.1585.

YANG X B, YU Y, XU J Q, et al . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study[J ] . Lancet Respir Med, 2020, 8(5): 475-481. DOI:10.1016/S2213-2600(20)30079-5.

MIDDELDORP S, COPPENS M, VAN HAAPS T F, et al . Incidence of venous thromboembolism in hospitalized patients with COVID-19[J ] . J Thromb Haemost, 2020, 18(8): 1995-2002. DOI:10.1111/jth.14888.

VINER R M, WHITTAKER E. Kawasaki-like disease: emerging complication during the COVID-19 pandemic[J]. Lancet, 2020, 395(10239): 1741-1743. DOI:10.1016/S0140-6736(20)31129-6.

JONES V G, MILLS M, SUAREZ D, et al . COVID-19 and Kawasaki disease: novel virus and novel case[J ] . Hosp Pediatr, 2020, 10(6): 537-540. DOI:10.1542/hpeds.2020-0123.

SOKOLOVSKY S, SONI P, HOFFMAN T, et al . COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult[J ] . Am J Emerg Med, 2021, 39: 253.e1-253.e2. DOI:10.1016/j.ajem.2020.06.053.

[ODA R, INAGAKI T, ISHIKANE M, et al . Case of adult large vessel vasculitis after SARS-CoV-2 infection[J ] . Ann Rheum Dis, 2020: annrheumdis-2020-218440. DOI: 10.1136/annrheumdis-2020-218440 http://dx.doi.org/10.1136/annrheumdis-2020-218440 ..

NAGASHIMA S, MENDES M C, CAMARGO MARTINS A P, et al . Endothelial dysfunction and thrombosis in patients with COVID-19-brief report[J ] . Arterioscler Thromb Vasc Biol, 2020, 40(10): 2404-2407. DOI:10.1161/ATVBAHA.120.314860.

ZOU X, CHEN K, ZOU J W, et al . Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection[J ] . Front Med, 2020, 14(2): 185-192. DOI:10.1007/s11684-020-0754-0.

BIAN X W, YAO X H, PING Y F, et al . Autopsy of COVID-19 patients in China[J ] . Nat Sci Rev, 2020, 7(9):1414-1418. DOI:10.1093/nsr/nwaa123.

[PÉREZ-BERMEJO J A, KANG S, ROCKWOOD S J, et al . SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients[J ] . bioRxiv, 2020.[Online ahead of print ] . DOI: 10.1101/2020.08.25.265561 http://dx.doi.org/10.1101/2020.08.25.265561 ..

SHARMA A, GARCIA G, WANG Y Z, et al .Human ipsc-derived cardiomyocytes are susceptible to SARS-COV-2 infection[J ] . Cell Rep Med, 2020, 1(4): 100052. DOI:10.1016/J.XCRM.2020.100052.

[HUANG C, HUANG L, WANG Y, et al . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study[J ] . Lancet, 2021.[Online ahead of print ] . DOI: 10.1016/S0140-6736(20)32656-8 http://dx.doi.org/10.1016/S0140-6736(20)32656-8 ..

INCIARDI R M, LUPI L, ZACCONE G, et al . Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)[J ] . JAMA Cardiol, 2020, 5(7): 819-824. DOI:10.1001/jamacardio.2020.1096.

WU Q, ZHOU L N, SUN X, et al . Altered lipid metabolism in recovered SARS patients twelve years after infection[J ] . Sci Rep, 2017, 7(1): 9110. DOI:10.1038/s41598-017-09536-z.

HONG N, DU X K. Avascular necrosis of bone in severe acute respiratory syndrome[J]. Clin Radiol, 2004, 59(7): 602-608. DOI:10.1016/j.crad.2003.12.008.

ANTONIO G E, WONG K T, HUI D S C, et al . Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience[J ] . Radiology, 2003, 228(3): 810-815. DOI:10.1148/radiol.2283030726.

PUNTMANN V O, CARERJ M L, WIETERS I, et al . Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)[J ] . JAMA Cardiol, 2020, 5(11): 1265-1273. DOI:10.1001/jamacardio.2020.3557.

[XIA L T, HUANG L, FENG X, et al . Chronobiological patterns of acute aortic dissection in central China[J ] . Heart, 2020: heartjnl-2020-317009. DOI: 10.1136/heartjnl-2020-317009 http://dx.doi.org/10.1136/heartjnl-2020-317009 ..

中国医师协会胸痛专业委员会, 中国医师协会心血管内科医师分会, 中国胸痛中心联盟, 等.新冠肺炎流行期间胸痛中心常态化运行流程专家共识[EB/OL].[2020-02-10].

Committee of Chest Pain of Chinese Medical Doctor Association, Cardiovascular Physician Branch of Chinese Medical Doctor Association, Chinese Chest Pain Center Alliance, et al. Expert consensus on normal operation of chest pain center during the period of COVID-19 epidemic[EB/OL].[2020-02-10].

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

新型冠状病毒肺炎疫情早期青年军人风险认知的地区特征

基于胸部CT图像的肺炎深度学习分类预测模型

新冠肺炎患者肝肾功能损害的临床特征及其与重症及死亡的相关性分析